Back
Edge
StocktwitsEarnings
Official STOCKTWITS Representative

symbol logo$BVS Q3 '26 Earnings Results & Recap

• Reported GAAP EPS of $0.17 up 13.33% YoY • Reported revenue of $142.44M up 2.73% YoY • Bioventus reaffirmed FY2026 Adjusted EPS guidance of $0.75 to $0.79 per diluted share, with net sales guidance of $590M to $595M and Adjusted Cash from Operations of $84M to $89M.

Price since post

Full Details

Advertisement|Remove ads.